Clinical Trial Update: A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Brepocitinib for adults with cutaneous sarcoidosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Sarcoidosis

Drugs mentioned

• Brepocitinib (brepocitinib)

Snippet

Sponsor: Priovant Therapeutics, Inc. | Conditions: Cutaneous Sarcoidosis | Phase 2 | Status: RECRUITING